Shockwave Medical (Nasdaq:SWAV) - Prezzo delle azioni, notizie e analisi

SWAV Panoramica delle azioni

A medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. Maggiori dettagli

SWAV analisi fondamentale
Punteggio fiocco di neve
Valutazione	1/6
Crescita futura	3/6
Prestazioni passate	3/6
Salute finanziaria	5/6
Dividendi	0/6

Premi

Si prevede che gli utili cresceranno del 18.35% all'anno

Analisi del rischio

Gli azionisti sono stati diluiti nell'ultimo anno

I margini di profitto (20.7%) sono inferiori rispetto allo scorso anno (43.2%)

Shockwave Medical, Inc. Concorrenti

Globus Medical

NYSE:GMED

US$11.3b

Insulet

NasdaqGS:PODD

US$18.4b

Inspire Medical Systems

NYSE:INSP

US$5.3b

Masimo

NasdaqGS:MASI

US$8.8b

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per Shockwave Medical
Prezzi storici delle azioni
Prezzo attuale dell'azione	US$334.75
Massimo di 52 settimane	US$334.90
Minimo di 52 settimane	US$157.00
Beta	0.88
1Variazione di 1 mese	1.49%
Variazione a 3 mesi	27.08%
Variazione di 1 anno	15.77%
3Variazione a 3 anni	97.43%
Variazione a 5 anni	432.11%
Variazione dall'IPO	997.54%

Notizie e aggiornamenti recenti

Recent updates

Shockwave Medical, Inc.'s (NASDAQ:SWAV) 28% Jump Shows Its Popularity With Investors

Apr 06

Is Now An Opportune Moment To Examine Shockwave Medical, Inc. (NASDAQ:SWAV)?

Mar 24

Shockwave Medical: Opening Arteries, Delivering Returns

Feb 28

Shockwave Medical, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Feb 18

There's Been No Shortage Of Growth Recently For Shockwave Medical's (NASDAQ:SWAV) Returns On Capital

Feb 06

Calculating The Fair Value Of Shockwave Medical, Inc. (NASDAQ:SWAV)

Jan 24

Some Shareholders Feeling Restless Over Shockwave Medical, Inc.'s (NASDAQ:SWAV) P/E Ratio

Jan 09

Rendimenti per gli azionisti

	SWAV	US Medical Equipment	US Mercato
7D	0.2%	-0.4%	-1.0%
1Y	15.8%	20.3%	30.3%

Ritorno vs Industria: SWAV ha superato il US Medical Equipment che ha restituito 20.3 % nell'ultimo anno.

Rendimento vs Mercato: SWAV ha avuto una performance inferiore al mercato US che ha registrato un rendimento 30.3 % nell'ultimo anno.

Volatilità dei prezzi

Is SWAV's price volatile compared to industry and market?
SWAV volatility
SWAV Average Weekly Movement	3.6%
Medical Equipment Industry Average Movement	8.2%
Market Average Movement	6.2%
10% most volatile stocks in US Market	15.7%
10% least volatile stocks in US Market	3.1%

Prezzo delle azioni stabile: SWAV non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale ( 4% ) di SWAV è rimasta stabile nell'ultimo anno.

Informazioni sull'azienda

Fondato	I dipendenti	AMMINISTRATORE DELEGATO	Sito web
2009	1,468	Doug Godshall	shockwavemedical.com

Shockwave Medical, Inc. Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di Shockwave Medical con la sua capitalizzazione di mercato?
SWAV statistiche fondamentali
Capitalizzazione di mercato	US$12.57b
Guadagni(TTM)	US$163.50m
Ricavi(TTM)	US$787.97m

76.9x

Rapporto P/E

15.9x

Rapporto P/S

SWAV è sopravvalutato?

Vedi Fair Value e analisi di valutazione

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
SWAV Conto economico (TTM)
Ricavi	US$787.97m
Costo del fatturato	US$102.53m
Profitto lordo	US$685.44m
Altre spese	US$521.94m
Guadagni	US$163.50m

Ultimi guadagni dichiarati

Mar 31, 2024

Prossima data di guadagno

Aug 05, 2024

Utile per azione (EPS)	4.35
Margine lordo	86.99%
Margine di profitto netto	20.75%
Rapporto debito/patrimonio netto	97.5%

Come si è comportato SWAV nel lungo periodo?

Vedi performance storica e confronto

SWAV Panoramica delle azioni

Premi

Analisi del rischio

Shockwave Medical, Inc. Concorrenti

NYSE:GMED

US$11.3b

NasdaqGS:PODD

US$18.4b

NYSE:INSP

US$5.3b

NasdaqGS:MASI

US$8.8b

Storia dei prezzi e prestazioni

Notizie e aggiornamenti recenti

Shockwave Medical Unveils First Clinical Outcomes of New IVL Platform in Late-Breaking Presentation at VIVA 2024

Shockwave Medical, Inc. Announces U.S. Launch of the Shockwave E8 Peripheral Ivl Catheter

Shockwave Medical Files Form 15

Shockwave's Common Stock Ceases Trading on NASDAQ

Shockwave Medical, Inc. Announces Termination of Employment of Renee Gaeta as Chief Financial Officer

Johnson & Johnson (NYSE:JNJ) completed the acquisition of Shockwave Medical, Inc. (NasdaqGS:SWAV) from a group of sellers.

Recent updates

Shockwave Medical Unveils First Clinical Outcomes of New IVL Platform in Late-Breaking Presentation at VIVA 2024

Shockwave Medical, Inc. Announces U.S. Launch of the Shockwave E8 Peripheral Ivl Catheter

Shockwave Medical Files Form 15

Shockwave's Common Stock Ceases Trading on NASDAQ

Shockwave Medical, Inc. Announces Termination of Employment of Renee Gaeta as Chief Financial Officer

Johnson & Johnson (NYSE:JNJ) completed the acquisition of Shockwave Medical, Inc. (NasdaqGS:SWAV) from a group of sellers.

Shockwave Medical Withdraws Earnings Guidance for the Full Year 2024

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Shockwave Medical, Inc., Annual General Meeting, May 29, 2024

Price target increased by 7.7% to US$302

Shockwave Medical, Inc. Announces Investigators Presented Six-Month Data from the Full Population of the Reducer-I Study

Johnson & Johnson (NYSE:JNJ) entered into a definitive agreement to acquire Shockwave Medical, Inc. (NasdaqGS:SWAV) for $13 billion.

Shockwave Medical, Inc.'s (NASDAQ:SWAV) 28% Jump Shows Its Popularity With Investors

Johnson & Johnson (NYSE:JNJ) entered into a definitive agreement to acquire Shockwave Medical, Inc. (NasdaqGS:SWAV) for $13 billion.

Price target increased by 9.7% to US$286

Insufficient new directors

Johnson & Johnson Reportedly Considers Deal for Shockwave Medical

Chief Commercial Officer notifies of intention to sell stock

Is Now An Opportune Moment To Examine Shockwave Medical, Inc. (NASDAQ:SWAV)?

Independent Director notifies of intention to sell stock

Chief Commercial Officer notifies of intention to sell stock

Shockwave Medical: Opening Arteries, Delivering Returns

New minor risk - Shareholder dilution

Independent Director recently sold US$15m worth of stock

Now 21% undervalued

Consensus EPS estimates increase by 12%

President exercised options and sold US$2.3m worth of stock

Shockwave Medical, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Full year 2023 earnings: EPS exceeds analyst expectations

Shockwave Medical, Inc. Provides Earnings Guidance for 2024

There's Been No Shortage Of Growth Recently For Shockwave Medical's (NASDAQ:SWAV) Returns On Capital

Shockwave Medical, Inc. Appoints Renee Gaeta as Chief Financial Officer, Effective February 5, 2024

Chief Commercial Officer notifies of intention to sell stock

Calculating The Fair Value Of Shockwave Medical, Inc. (NASDAQ:SWAV)

President notifies of intention to sell stock

Shockwave Medical, Inc. to Report Q4, 2023 Results on Feb 15, 2024

Some Shareholders Feeling Restless Over Shockwave Medical, Inc.'s (NASDAQ:SWAV) P/E Ratio

President notifies of intention to sell stock

Is Shockwave Medical (NASDAQ:SWAV) A Risky Investment?

Chief Commercial Officer notifies of intention to sell stock

President exercised options and sold US$922k worth of stock

Do Shockwave Medical's (NASDAQ:SWAV) Earnings Warrant Your Attention?

Now 21% undervalued after recent price drop

President notifies of intention to sell stock

What Is Shockwave Medical, Inc.'s (NASDAQ:SWAV) Share Price Doing?

Investor sentiment deteriorates as stock falls 25%

Shockwave Medical, Inc. Announces New Data Demonstrating One-Year Outcomes with Coronary Lithotripsy

Now 22% undervalued after recent price drop

Shockwave Medical, Inc. Provides Revenue Guidance for the Full Year 2023

Third quarter 2023 earnings: EPS exceeds analyst expectations

Price target decreased by 13% to US$241

Shockwave Medical, Inc. Introduces Enhanced Coronary IVL Catheter in the United States

Shockwave Medical, Inc. Announces New Shockwave Coronary IVL Publications Confirm Safety and Efficacy Across Multiple Calcium Morphologies

Is Shockwave Medical, Inc. (NASDAQ:SWAV) Trading At A 50% Discount?

President notifies of intention to sell stock

Shockwave Medical (NASDAQ:SWAV) Is Very Good At Capital Allocation

Shockwave Medical (NASDAQ:SWAV) Has A Rock Solid Balance Sheet

President notifies of intention to sell stock

Shockwave Medical, Inc. Appoints Nick West as Associate Chief Medical Officer